Department of Pharmacology and Therapeutics, Room 1314, McIntyre Medical Sciences Building, McGill University, 3655 Promenade Sir William Osler, Montreal, QC, H3G 1Y6, Canada.
Trends Pharmacol Sci. 2013 Sep;34(9):497-507. doi: 10.1016/j.tips.2013.07.002. Epub 2013 Aug 1.
Optimal enzyme activity is essential for maintenance of physiological homeostasis. A variety of both non-genetic and genetic disruptions can excessively activate or silence intrinsic enzyme activities, with pathological outcomes. Many pharmacological agents are activators and inhibitors of enzymes. It is essential, therefore, in the development of drugs as enzyme activators and inhibitors, that enzyme activities be accurately measured under physiological and pathological conditions. Different biochemical assays have been developed for this purpose, some of which are based on nanostructured materials. This review focuses on gold nanoparticle (GNP)-based structures for the sensing and measurement of enzyme activities in biological specimens. Here we provide an overview and critical analysis of such assays, identify their advantages and limitations, and discuss interesting features of GNPs to be exploited for future applications in pharmacology.
最佳的酶活性对于维持生理内稳态至关重要。各种非遗传和遗传的干扰都可能过度激活或沉默内在的酶活性,从而导致病理后果。许多药理制剂都是酶的激活剂和抑制剂。因此,在开发作为酶激活剂和抑制剂的药物时,必须在生理和病理条件下准确测量酶活性。为此目的已经开发了不同的生化测定法,其中一些基于纳米结构材料。本综述重点介绍了基于金纳米粒子(GNP)的结构,用于生物样本中酶活性的检测和测量。在这里,我们对这些测定法进行了概述和批判性分析,确定了它们的优点和局限性,并讨论了 GNP 的有趣特性,以便在未来的药理学应用中加以利用。